Every GP contract year reshapes what lands on a practice’s desk, and the 2026/27 year is no exception. Most coverage focuses on the headline numbers, the funding mechanisms and the indicator changes. Useful as that is, it tends to skip the part that quietly fills inboxes and clinical sessions: medicines. Prescriptions, reviews, monitoring, queries and optimisation work all grow whenever a contract pushes harder on access, long-term conditions and quality.
This post takes a deliberately narrow view. Rather than walking through the whole contract, it looks at the themes that shape a practice’s medicines workload under the GP contract 2026/27 and what a sensible response looks like. We have kept it thematic on purpose. For the exact figures, indicator definitions, thresholds and dates, the official documentation from the BMA and NHS England is the source to rely on, and you should check it directly before making any planning decisions.
Why medicines workload moves when the contract moves
Medicines sit downstream of almost everything a contract asks of a practice. A push on access generates more appointments, and more appointments generate more prescribing and more follow-up. A focus on long-term conditions brings reviews, titration and ongoing monitoring. A focus on quality and safety adds structured checks on the drugs that carry the most risk. None of this is new. What each contract year changes is the balance, and the medicines tail is usually longer than the headline suggests.
The practical effect is that medicines work expands in ways that are hard to see on a rota. A repeat prescribing queue does not announce itself the way a full waiting room does, yet it absorbs hours of clinical and administrative time every week. When a contract year leans into access and outcomes, that hidden work tends to grow first.
The themes shaping the year
Contract years differ in detail, but the recurring themes are familiar. Each one carries a medicines consequence worth planning for.
Access
Improving patient access remains a central thread of NHS primary care policy. More contacts, however they are delivered, mean more prescribing decisions, more medication starts and stops, and more queries flowing back into the practice. The medicines workload that follows an access drive is easy to underestimate because most of it arrives after the appointment rather than during it.
Workload and sustainability
Workload pressure is the backdrop to every contract conversation. Practices are asked to do more within the same clinical day, and medicines work is one of the areas where that pressure shows up as backlog: prescription queries that wait, reviews that slip, monitoring that drifts past its due date. Tackling it is partly about who does the work and partly about how reliably it gets done.
Long-term conditions
The shift toward proactive long-term condition management has clear medicines implications. Patients with multiple conditions take multiple medicines, and keeping those regimens safe, effective and appropriate is ongoing work rather than a one-off task. Reviews, deprescribing where appropriate and careful monitoring all sit here, and they scale with the size of a practice’s at-risk population.
Medicines optimisation
Medicines optimisation is the theme most directly in scope. It covers getting the best outcomes from medicines, reducing avoidable harm and waste, and keeping prescribing in step with current evidence and local formularies. It is also where structured clinical pharmacy input makes the most visible difference, because it is detailed, repeatable work that benefits from dedicated clinical attention. You can read more about how we approach this on our medicines optimisation page.
Incentives and quality
Quality frameworks continue to reward better management of specific conditions and safer prescribing, with QOF the current scheme most practices will know well. PCN-level incentives also shape priorities. What is rewarded, and how, changes from year to year, so check the official documentation rather than relying on last year’s assumptions. The constant is that much of what these frameworks measure is medicines-related, which means clinical pharmacy work often feeds directly into a practice’s quality position.
What this means in the consulting room and the back office
Translated into day-to-day terms, a contract year that leans on access, long-term conditions and quality tends to produce more of the following:
- Structured medication reviews for patients on multiple medicines or with conditions that need regular oversight.
- Monitoring of high-risk drugs, where missed bloods or overdue checks carry real clinical and safety consequences.
- Prescription and medicines queries from patients, community pharmacies and secondary care.
- Prescribing changes driven by formulary updates, safety alerts and cost-effectiveness work.
- Audit and data work to support quality reporting and to find patients who need attention.
Each of these is clinical work that has to be done well, not just done. That is the crux of the planning problem: the volume rises while the standard cannot drop.
Responding without simply adding hours
The instinct when workload rises is to find more time, but raw time is the scarcest thing in general practice. A more durable response is to make sure the medicines work that grows under a new contract year is handled reliably, to a consistent standard, by people whose job is precisely that.
This is where a managed clinical pharmacy service differs from simply finding extra pairs of hands. A staffing or agency arrangement places a person and leaves the practice carrying everything around them: the governance, the quality assurance, the continuity risk, and the accountability when someone is off or moves on. A managed service is built differently. The provider holds clinical governance and quality assurance for the work it delivers, takes responsibility for accountability and continuity, and delivers against an agreed scope rather than slotting a person into a gap.
At Virtual Pharmacist we deliver this remotely, working inside the practice’s own clinical system rather than from the outside. The team is made up of GPhC-registered pharmacists and pharmacy technicians, and the service is wrapped in a full information governance stack including NHS DSPT, Cyber Essentials, HSCN connectivity and the relevant data sharing agreements. You can see how that governance is structured on our clinical governance and data security page. The clinical pharmacy work itself sits within your practice’s own CQC registration and clinical governance, and our pharmacists are regulated by the GPhC, so the arrangement fits the way general practice is already overseen.
Where managed support fits the contract themes
Mapped against the themes above, managed clinical pharmacy support lines up with the medicines work each one creates.
- Long-term conditions and reviews. Structured, consistent clinical medication reviews that keep regimens safe and appropriate as patient numbers grow.
- Safety and quality. Reliable high-risk drug monitoring, so the checks that matter most do not slip past their due dates.
- Medicines optimisation. Prescribing support, formulary alignment and waste reduction handled as ongoing work rather than an occasional project.
- Workload and backlog. Day-to-day medicines query handling and prescribing support that keeps the queue moving.
For PCNs, the same logic applies at scale, and managed support can sit alongside the way networks already use their funding, including Additional Roles funding. Our ARRS support page gives a useful overview for practices and networks weighing up that route. ICBs taking a population-wide view of medicines, and PCNs looking at the wider organisational picture, can talk to us about how a managed approach fits alongside their own teams.
Planning ahead, sensibly
The most useful thing a practice can do at the start of a contract year is to look at its medicines workload honestly. Where is the backlog? Which monitoring is at risk of slipping? Which patient groups will generate the most review work as the year’s priorities bite? Answering those questions gives you a clearer view than any headline figure, and it shows you where dedicated clinical pharmacy attention would do the most good.
From there, decide what your own team should hold and what would be better delivered as a managed service with its own governance and continuity. The aim is not to bolt on hours but to make sure the medicines work that grows under the 2026/27 contract is done well and done dependably, whatever the year’s detail turns out to be once you have read it in the official BMA and NHS England documentation.
Frequently asked questions
Where can I find the exact 2026/27 GP contract figures and indicators?
The official BMA and NHS England contract documentation is the authoritative source for figures, indicator definitions, thresholds and dates. We have kept this article thematic on purpose, because contract specifics change and only the official documents should be used for planning.
How does a new contract year affect medicines workload specifically?
Medicines work follows on from most contract priorities. Drives on access, long-term condition management and quality tend to produce more prescribing, more medication reviews, more monitoring and more queries, so medicines workload usually grows even when the headline focus is somewhere else.
What is the difference between a managed clinical pharmacy service and hiring or using an agency?
A staffing or agency arrangement places a person and leaves the practice holding governance, quality assurance, continuity and accountability. A managed service delivers an agreed scope of work, with the provider holding clinical governance, quality assurance, accountability and continuity for that work.
Does clinical pharmacy support affect our CQC position?
Clinical pharmacy work in general practice sits within your practice’s own CQC registration and clinical governance, and the pharmacists are regulated by the GPhC. A managed service is designed to fit that existing oversight rather than sit outside it.
Can remote pharmacy support work inside our clinical system?
Yes. Virtual Pharmacist works remotely inside the practice’s own clinical system, such as EMIS, SystmOne or Medicus, supported by an information governance stack including NHS DSPT, Cyber Essentials, HSCN and data sharing agreements.
If you want to look ahead at what the 2026/27 contract year means for your medicines workload, we would be glad to talk it through. Whether you are a GP practice, a PCN or an ICB, contact Virtual Pharmacist to discuss your needs and how managed clinical pharmacy support could fit.
